Chinese Non-Invasive BCI Developer Zhongke Huayi Secures Pre-A and Pre-A+ Funding Rounds, Advances Toward IPO

Nov 28, 2024 17:46 CST Updated 17:46

NeurPlus

Precision EEG Measurement and Intelligent Wearable Medical Device Developer

Instrument Family

Medical Device Media Reporting Pioneer

Share Professional Medical Device Knowledge

Source:Public Information on the Internet, Investment and Health

Recently,NeurPlus Announces Successful Completion of Pre-A and Pre-A+ Rounds of Financing Worth Tens of Millions of RMBJointly participated by Taiyu Investment, Zhongke Angel, Seven Seas Capital, and Linchuang Sinan Fund, the funds will be mainly used to accelerate the market expansion of approved non-invasive neuromodulation products such as transcranial electrical stimulators, develop new product pipelines, advance clinical trials, and expand the team, further enhancing NeurPlus's industry position in the field of non-invasive precise deep brain neuromodulation.

NeurPlusShenzhen Institute of Advanced Technology, Chinese Academy of Sciences: Brain Cognition and Brain Disease InstituteNeurPlus, incubated and established, focuses on the innovative R&D of non-invasive closed-loop neuromodulation technology, creating a technology transformation platform. Through physical intervention methods, it provides diversified intervention, treatment, and rehabilitation solutions for brain function disorders. The product line covers various mental and nervous system diseases such as cognitive impairment, Alzheimer's disease, consciousness disorders, epilepsy, depression, and autism.

As an innovative medical enterprise with cross-disciplinary integration, NeurPlus brings together multidisciplinary talents from fields such as neuroscience, psychology, materials science, and biomedical engineering. It has built a non-invasive closed-loop neuromodulation technology platform and innovatively developed the "BCI+tES" personalized neuromodulation solution.

Based on profound technical reserves, NeurPlus has made several breakthrough advancements in non-invasive neural stimulation positioning, closed-loop algorithms, integrated multi-channel stimulation chips, and electrode materials, laying a solid foundation for comprehensive transformation from scientific research to clinical applications.

With the advancement of technology, current neuromodulation techniques are trending towards precision, targeting, non-invasiveness, and closed-loop systems. NeurPlus, with the approach of "BCI brain-computer interface + tES transcranial electrical stimulation," focuses on individualized non-invasive deep brain precise closed-loop neuromodulation technology. It innovatively develops a closed-loop transcranial temporal interference deep brain stimulator with fully independent intellectual property rights.

As the world's leading non-invasive, personalized, precise, closed-loop deep brain modulation platform based on brain-computer interface,Closed-loop Transcranial Temporal Interference Deep Brain Stimulation Breakthrough: Overcoming Technical Bottlenecks of Limited Stimulation Depth, Insufficient Target Focus, and Poor Real-time Performance in Traditional Transcranial Electrical Stimulation. This technological platform provides an integrated intelligent solution for scientific research and clinical applications, enabling personalized whole-brain precise localization analysis and non-invasive deep brain stimulation. In the future, it can be applied to cutting-edge neuroscience research and the treatment of various neurological and psychiatric disorders, including cognitive impairment, Alzheimer's disease, disorders of consciousness, epilepsy, depression, and attention deficit hyperactivity disorder (ADHD).

Transcranial Electrical Stimulator Receives Medical Device Registration Approval. Based on clinical expert consensus and guidelines, this product utilizes non-invasive neuro-electrical stimulation technology. Electrodes placed on the scalp deliver low-intensity current to the cerebral cortex, altering cortical excitability, enhancing synaptic plasticity, and influencing functional connectivity of neural networks. It provides personalized and precise non-invasive electrical stimulation targeting the prefrontal cortex region, combined with intelligent parameter configuration, offering a wide range of individualized modulation solutions for clinical use.

Transcranial Electrical Stimulator, Closed-loop Transcranial Temporal Interference Deep Electrical Stimulator, Animal Transcranial Electrical Stimulator

Source: NeurPlus

In the future, NeurPlus will continue to strengthen its technical advantages, accelerate market expansion in the field of non-invasive precision brain neuromodulation, and provide high-quality treatment solutions for patients with neurological disorders through multi-indication product layouts and platform technology innovation. It is committed to promoting the global application and development of non-invasive neuromodulation technology.

END

Industry Giant Announces Restructuring, Stock Price Soars 29%

Backed by 110 Million People, Beijing to Introduce World-Class International Hospitals

Minimally Invasive and Neusoft Bet on the Only Surgical Robot Approved in China

Boston Scientific, Second Acquisition This Month

World's First Self-Shielding Radiotherapy Robot to Be Mass-Produced in China

China-produced New Generation 7T MRI Wins 85.6 Million RMB Bid at Qilu Hospital of Shandong University

Philips, Joining Hands with "World's First"

CGM Leader, Entering the 36.2 Billion Yuan "Ring" Market

Next week, the world's largest medical imaging event is coming.

Siemens Healthineers + Dental Leader: The World's First Dental MRI is Here

BusinessBusiness cooperation email: qxzj@landianyiliao.com